Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
about
Prophylactic antibiotics for preventing recurrent symptomatic episodes of acute diverticulitisNon-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease.A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial).Italian consensus conference for colonic diverticulosis and diverticular disease.Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.Effect of oral mesalamine on inflammatory response in acute uncomplicated diverticulitis.Mesalazine for diverticular disease of the colon--a new role for an old drug.Advances in the management of colonic diverticulitis.5-aminosalicylic acid agents for prevention of recurrent diverticulitis: a systematic review and meta-analysis.Management of diverticular disease is changing.New physiopathological and therapeutic approaches to diverticular disease of the colon.New strategies for the management of diverticular disease: insights for the clinician.Diverticular disease and diverticulitis.Preventing recurrent acute diverticulitis with pharmacological therapiesAssociation Between Colonic Diverticulosis and Erectile Dysfunction: A Nationwide Population-Based Study.Probiotics and diverticular disease.Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis--a prospective randomized study.Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.Aminosalicylates.Systematic review of medical therapy to prevent recurrent diverticulitis.Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.Increased risk for irritable bowel syndrome after acute diverticulitis.Systematic review of evidence and consensus on diverticulitis: an analysis of national and international guidelines.Changes in the approach to acute diverticulitis.Metformin use in diabetics with diverticular disease is associated with reduced incidence of diverticulitis.Rifaximin in the management of colonic diverticular disease.Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines.Diverticular disease: A therapeutic overview.The medical and nonoperative treatment of diverticulitis.Clinical presentation and risks.Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?Diverticular Disease in the Elderly
P2860
Q24201705-146E1B95-1A2F-4D80-98CD-C5B85A9B1AFFQ33459930-54437B00-8E63-43AD-95AB-35329DF380EBQ33636727-F04CE723-A0C9-4F73-95CA-2A58E697A8A7Q34418890-7DE1FE98-708D-4C9D-9E6B-ABF7BAE3CBB2Q34486456-EE3BADCA-1204-4681-9449-B1A898F82973Q35803757-9AED0BBC-219D-48AC-B949-3EDC49F1B79FQ35865255-89B97735-0F7B-4406-B54C-380ABADE3BE1Q36040685-543BB124-F243-46A1-BA75-EBB90869FCC2Q36247374-611EEC8A-A50C-4494-90D4-B38921BBF966Q36407885-EB55B442-9C25-4E5B-9158-A8D0AFCEEB98Q36485821-21BFDFE2-500D-4E0C-803D-3DFC187E3946Q36723833-EAE39EE2-D3EA-4FEB-9873-75B7632DDC4CQ36761883-D999F9B2-2135-4D36-838B-E5A2F21061A2Q37163545-15AD3511-3186-4D8E-B9F6-49A5B04BFA98Q37253907-9A9ABBA2-C810-4407-8A13-E606C42FD385Q37328552-1F2DDD21-4B3E-42EF-B46D-5431CCDCA736Q37401590-A99D8743-4266-45A7-AEDB-12B5DCADED64Q37605593-FE75C56B-E1F1-40D7-8025-05D6BFECA3AEQ37768415-7C0D940A-4386-4403-AA74-431B4DE54D81Q37874981-161F1949-38B9-458B-92B9-0EF54028B745Q38008871-73CE024B-67AE-4734-A032-0C370EE44F26Q38009264-1D2378B7-0E05-4B93-A314-FA28675B0176Q38024998-BFEFABC2-6EB0-4349-8491-BFE3AA04B348Q38092548-5E08BEB1-D610-4BD8-BEAC-C3527165C6B9Q38209797-14477E2D-86A8-4A0A-96DA-57967C90C045Q38554576-21105307-49C3-4D18-9D13-78E8E45CAFA7Q38786406-40DD6A3A-0D93-4473-9D07-6B13EC37B067Q39295479-00A55FD7-0959-465E-BE7C-F45000031FA4Q40995957-BF8AAE56-E5D1-44A1-989F-29520D80B20AQ41875201-A1130CB1-A4CB-497E-9DEE-6BB534FC4EA9Q42653528-F47642E3-AAE1-4C98-B162-117A83E9B1C2Q47786581-65756B17-8E0F-4DAD-870C-9BE5FBA4936EQ47873157-44380318-36B4-4A03-A94D-8A53CE1892AAQ53177620-69BE1D6E-FD85-4A62-B70E-9C7900EE78D2Q54196703-D057D1C7-D0D4-4122-9DB0-8FB4D444F4B8
P2860
Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Long-term treatment with mesal ...... acute diverticulitis of colon.
@ast
Long-term treatment with mesal ...... acute diverticulitis of colon.
@en
Long-term treatment with mesal ...... acute diverticulitis of colon.
@nl
type
label
Long-term treatment with mesal ...... acute diverticulitis of colon.
@ast
Long-term treatment with mesal ...... acute diverticulitis of colon.
@en
Long-term treatment with mesal ...... acute diverticulitis of colon.
@nl
prefLabel
Long-term treatment with mesal ...... acute diverticulitis of colon.
@ast
Long-term treatment with mesal ...... acute diverticulitis of colon.
@en
Long-term treatment with mesal ...... acute diverticulitis of colon.
@nl
P2093
P1476
Long-term treatment with mesal ...... acute diverticulitis of colon.
@en
P2093
P304
P356
10.1016/S1590-8658(02)80110-4
P577
2002-07-01T00:00:00Z